Elder Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
454 Life Sciences
Genome Sequencer 20 System launched for high-throughput DNA sequencing
October 26th, 2005
454 Life Sciences, a majority-owned subsidiary of CuraGen Corp. (CRGN), and Roche announced the commercial launch, including worldwide sales and distribution, of the Genome Sequencer 20 System and reagents from 454 Life Sciences by Roche Applied Science. 454 Life Sciences' technology will enable researchers to sequence up to 100 times faster than current commercial platforms at a fraction of the price. Roche Applied Science, a business area of Roche Diagnostics, is now selling 454 Life Sciences' products through its extensive sales and marketing teams, distributing 454's products through its established supply chain, and providing technical support to purchasers of the...
Source: Elder Law Weekly (2005-10-26)
|
